Therapy of Type 2 diabetes: more gliflozines and less metformin?

Verdecchia, Paolo; Murdolo, Giuseppe; Coiro, Stefano; Santucci, Andrea; Notaristefano, Francesco; Angeli, Fabio; Cavallini, Claudio

Verdecchia, Paolo; Murdolo, Giuseppe; Coiro, Stefano; Santucci, Andrea; Notaristefano, Francesco; Angeli, Fabio; Cavallini, Claudio.

Afiliación

Verdecchia P; Umbra Heart and Hypertension Foundation-ONLUS and Department of Cardiology, S. Maria della Misericordia Hospital, Perugia, Italy.
Murdolo G; Department of Internal Medicine, Endocrine and Metabolic Sciences (MISEM), S. Maria della Misericordia Hospital, Perugia Hospital, Perugia, Italy.
Coiro S; Department of Cardiology, S. Maria della Misericordia Hospital, Perugia, Italy.
Santucci A; Department of Cardiology, S. Maria della Misericordia Hospital, Perugia, Italy.
Notaristefano F; Department of Cardiology, S. Maria della Misericordia Hospital, Perugia, Italy.
Angeli F; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Cavallini C; Department of Cardiopulmonary Medicine and Rehabilitation, Maugeri IRCCS Clinical Scientific Institutes, Tradate, Italy.

Eur Heart J Suppl ; 25(Suppl B): B171-B176, 2023 Apr.

Article en En | MEDLINE | ID: mdl-37091638

Palabras clave

Diabetes mellitus; Gliflozines; Metformin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur Heart J Suppl Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google